Add this topic to your myFT Digest for news straight to your inbox
Federal Trade Commission said it secured concessions from pharma company to resolve its competition concerns
Dublin believes that the country’s skill base will attract pharma and medical companies
Suggestion opportunities yielded by lower cost of technology are not adequately recognised by government
Challenges include getting multiple gene edits right, creating artificial wombs and building a herd with sufficient diversity
Drugmaker says it is working on new technologies to develop vaccines for infectious diseases where there is ‘high unmet need’
Illumina-owned cancer testing group allegedly failed to deal with accusations of inappropriate behaviour and racism
US gene sequencing company proceeded with acquisition of cancer test developer even as regulators were probing deal
We have a narrow window during which to harness AI for good, rather than ill
Move by Food and Drug Administration paves way for millions of Americans to access medicine
Medicines produced by pharma group will be for domestic use only
World’s biggest gene sequencing group closed deal with cancer screening start-up despite ongoing investigation
Insilico Medicine says trial of lung disease therapy is milestone for generative AI in drug development
Antitrust challenge may force big pharma groups to rethink ‘pure play’ business models
Drugmakers’ appetite for takeovers surges but FTC action against Amgen raises risks for megadeals
Chief’s resignation follows chair’s departure from gene sequencing group
Pharmaceuticals producer in first court hearing on Monday
Quell Therapeutics is developing cell engineering that aims to treat autoimmune diseases
Error prompts life assurance customers to pause or review relationship with early detection biotech
World’s biggest gene sequencing company rejects EU’s fast- track application
Vote to remove John Thompson is the culmination of one of the largest shareholder activism campaigns in years
Government seeks to win over pharma groups with new investments in genomics research and drug manufacturing
Gene sequencing company heads for pivotal vote in battle with activist investor Carl Icahn
Development chief raises worry over innovation after FTC sues to block Amgen-Horizon deal
Leonard Schleifer supportive of FTC’s lawsuit against takeover of Horizon Therapeutics
US regulator sues to block takeover of biotech group Horizon Therapeutics
International Edition